Amyotrophic lateral sclerosis

N Engl J Med. 2001 May 31;344(22):1688-700. doi: 10.1056/NEJM200105313442207.

Authors

L P Rowland¹, N A Shneider

Affiliation

¹ Neurological Institute, Columbia-Persbyterian Medical Center, New York-Presbyterian Hospital, and Columbia University College of Physicians and Surgeons, NY 10032, USA. lprl@columbia.edu

PMID: 11386269
DOI: 10.1056/NEJM200105313442207

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, P.H.S.
Review

MeSH terms

Amyotrophic Lateral Sclerosis* / diagnosis
Amyotrophic Lateral Sclerosis* / etiology
Amyotrophic Lateral Sclerosis* / therapy
Environment
Genetic Predisposition to Disease
Humans
Motor Neurons / pathology
Motor Neurons / physiology
Mutation
Suicide, Assisted
Superoxide Dismutase / genetics*
Superoxide Dismutase / metabolism
Superoxide Dismutase-1

Substances

SOD1 protein, human
Superoxide Dismutase
Superoxide Dismutase-1